Separately, upon receipt of the full efficacy and safety results for the NORSE EIGHT clinical trial in the United States, which are expected in January 2025, Outlook Therapeutics plans to resubmit its ...
The global ophthalmic devices market was valued at $53,428.8 million in 2019, and is projected to reach $66,719.3 million by 2027, registering a CAGR of 4.2% from 2020 to 2027. The growth of the ...
Ophthalmic operating microscope is designed to provide high contrast and detailed imaging of all regions of the human eye. An apochromatic lens will provide high light transmission, permitting ...